Watson wins U.S. OK for generic Nicorette mint gum

"U.S. health regulators approved Watson Pharmaceuticals Inc's generic version of GlaxoSmithKline Plc's Nicorette mint gum, an over-the-counter product to help smokers quit, Watson said on Wednesday. Watson plans to make the product, known generically as Nicotine Polacrilex gum, available in early January. Watson won approval for the 2 milligram and 4 milligram strengths. The market for over-the-counter nicotine gum has annual sales of more than $300 million, according to Watson. California-based Watson said it has applications pending at the U.S. Food and Drug Administration to market more flavors of nicotine gum as it seeks to enhance its line of smoking cessation products" - Reuters